Investor Relations


We are a profitable and growing company focused on the acquisition, development and commercialization of branded prescription products for specialty physician market segments. Since our inception in 1999, we have successfully funded the acquisition and development of our product portfolio with limited external investment. We believe we have significant growth opportunities with our diversified product portfolio and we continue to identify and pursue other promising product candidates.

Data Provided by Refinitiv. Minimum 15 minutes delayed.